Clinical Trials
3 trialsNCT00057512 2016-02-23
Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck
Erimos Pharmaceuticals
Phase 1 Completed
NCT00154089 2016-02-23
A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
Erimos Pharmaceuticals
Phase 1/2 Completed
NCT00259818 2008-01-24
Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors
Erimos Pharmaceuticals
Phase 1 Completed